GLORIA trial findings show the safety and tolerability of tapering glucocorticoids in elderly RA patients
Phases IIa trial reports that tildrakizumab treatment did not improve ASAS20 response rate in ankylosing spondylitis patients
Study shows that sodium-glucose cotransporter-2 inhibitor use is linked to decreased risk for flare in adults with gout and type 2 diabetes
